Healthcare Sales & Marketing Network News: OXi4503

Searching News Database: OXi4503

HSMN NewsFeed - 20 Mar 2015
OXiGENE, Inc. Announces $10 Million At-the-Market Registered Direct Offering
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 16 May 2014
OXiGENE Names Experienced Biotech Executive, David J. Chaplin, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 21 Nov 2012
OXiGENE Announces OXi4503 Granted Orphan Designation for Treatment of Acute Myelogenous Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Feb 2010
OXiGENE Announces Restructuring to Focus Resources on Key Programs and Provides Business Update
Biopharmaceuticals

HSMN NewsFeed - 23 Oct 2008
OXiGENE, Inc. Names John A. Kollins as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Jul 2007
OXiGENE Appoints Patricia Walicke, M.D., Ph.D. as Chief Medical Officer
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 11

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 11 additional stories matching:
OXi4503
(Password required)

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!